Replies to post #93697 on DD Support Board and Research Team

[BeauBeau]

If Scott Sand was barred from Penny Stocks, then HOW on God's Green earth is his "Yorkshire Capital" allowed to be involved with FBEC?
Thank you in advance for ANY Replies!

Issue an Order barring Sand from participating in any offering of penny stock, pursuant to Section 20(g) of the Securities Act, 15 U.S.C. § 77t(g), and Section 21(d) of the Exchange Act,15 U.S.C. § 78u(d), for the violations alleged in this Complaint.

https://www.sec.gov/litigation/complaints/2010/comp-pr2010-187-sand.pdf

Did the above order NEVER get issued?

[stockmasterflash]

Robert Sand is Scott's Dad

And if I'm not mistaken, Scott once put out a shareholder letter regarding having to care for his Dad who had Alzheimers.

[stockmasterflash]

Still looking for the dementia post

But here is his Dad taking on a consulting gig at Scott's scam

http://biz.yahoo.com/e/071017/itec.pk8-k.html

From June 1, 2007 and July 9, 2007, Ingen issued an aggregate of 800,000 shares in exchange for consulting services. Pursuant to an agreement dated June 1, 2007, Ingen issued 200,000 shares of common stock to Christopher Wirth for consulting services related to development of applications for Ingen's various product lines. Mr. Wirth is a director of Ingen. The stock was valued at the market price on the date of issuance of $0.10 per share, or a total of $20,000. On July 5, 2007, pursuant to an agreement dated January 1, 2007 with GV Product Design & Engineering, Inc. ("GV"), Ingen issued 500,000 shares to Robert Sand, the president of GV. Robert Sand is the father of Ingen's CEO and Chairman, Scott Sand. GV was engaged to provide Ingen with product and engineering guidance for its OxyView and OxyAlert products for a period of two years. Under the terms of its agreement with Ingen, GV is due 500,000 shares of restricted common stock upon the completion of the design of OxyView and an additional 500,000 shares upon the completion of the design of OxyAlert. Ingen issued the first block of 500,000 shares to GV in the name of Robert Sand for the completion of the design of OxyView on July 5, 2007. The stock was valued at the market price on the date of issuance of $0.10 per share or a total of $50,000. On July 9, 2007, Ingen issued 100,000 shares of its restricted common stock to a consultant for design and marketing work on the SecureBalance product sold by Ingen. The stock was valued at the market price on the date of issuance of $0.10 per share, or a total of $10,000. Ingen issued the securities in reliance on the exemption from registration contained in Section 4(2) of the Securities Act of 1933 and/or Regulation D promulgated thereunder. There was no general solicitation or advertisement and resale restrictions were imposed by placing a Rule 144 legend on the stock certificates.